Bill

Bill > S400


NJ S400

Requires health insurers to provide coverage for treatment of tick-borne diseases.


summary

Introduced
01/09/2024
In Committee
01/09/2024
Crossed Over
Passed
Dead

Introduced Session

2024-2025 Regular Session

Bill Summary

This bill requires health insurers (health, hospital and medical service corporations, commercial individual and group health insurers, health maintenance organizations, health benefits plans issued pursuant to the New Jersey Individual Health Coverage and Small Employer Health Benefits Programs, the State Health Benefits Program, and the School Employees' Health Benefits Program) to provide coverage for expenses incurred in the treatment of a tick-borne disease. Treatment otherwise eligible for benefits pursuant to this bill may not be denied solely because such treatment may be characterized as experimental or investigational in nature or because the treatment requires the use of a prescription drug in an off-label manner.

AI Summary

This bill requires health insurers in New Jersey, including hospital service corporations, medical service corporations, health service corporations, individual and group health insurers, health maintenance organizations, and state and school employee health benefits programs, to provide coverage for expenses incurred in the treatment of tick-borne diseases, such as Lyme disease. This includes coverage for long-term antibiotic therapy and ongoing testing, and prohibits insurers from denying coverage solely because the treatment may be considered experimental or involves the use of a drug that is not FDA-approved, as long as the drug is recognized as medically appropriate or recommended by clinical studies.

Committee Categories

Business and Industry

Sponsors (1)

Last Action

Introduced in the Senate, Referred to Senate Commerce Committee (on 01/09/2024)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...